A groundbreaking study published in Research (2025, DOI: 10.34133/research.0545) has elucidated the molecular mechanisms by which protein phosphatase 2A (PP2A) regulates CD8+ T cell-mediated immune ...
HCW Biologics conducted investigative study to show safe dose levels of its lead drug candidate in non-human primates that were well tolerated at a level significantly higher than the identified ...
T cells, also known as T lymphocytes, are the immune cells that drive the cellular immune response. There are several different types of T cells, each playing a distinct role. The functions of T cells ...
SAN FRANCISCO, June 23, 2025 (GLOBE NEWSWIRE) -- AltruBio Inc. (“AltruBio” or “the Company”), a clinical stage biotech company developing novel immune checkpoint enhancers to address the unmet need in ...
Zeaxanthin, best known for eye health, has been found to boost the tumor-killing power of T cells. Researchers showed it ...
Researchers found that zeaxanthin, long associated with eye health, may also boost the body’s immune response against cancer. In a recent study, scientists at the University of Chicago found that ...
BRANFORD, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- EvolveImmune Therapeutics, an immuno-oncology company developing next-generation T cell engager biotherapeutics to overcome cancer cell resistance to ...
IN8bio announces INB-619, a novel γδ T cell therapy platform targeting CD19, showing promise in B cell depletion with reduced side effects. IN8bio, Inc. has announced the launch of its innovative γδ T ...
যে ফলাফলসমূহ আপনার কাছে অগম্য হতে পারে তা বর্তমানে দেখাচ্ছে।
অগম্য ফলাফলসমূহ লুকিয়ে ফেলুন
মতামত